Coya Therapeutics, Inc. (COYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 97.04M |
| Enterprise Value | 50.21M |
| P/E Ratio | -4.55 |
| PEG Ratio | -0.43 |
| Price/Sales Ratio | 14.25 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | -5,370.49 |
| Enterprise/EBITDA | 1,951.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.7 |
| Operating Margin | -2.82 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 7.95M |
| Revenue/Share | 0.34 |
| Gross Profit | 7.92M |
| EBITDA | -21.2M |
| Net Income | -21.23M |
| Diluted EPS | -1.27 |
| Total Cash | 43.18B |
| Total Cash/Share | 1,840.84 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.4 |
| Book Value Per Share | 1,844.89 |
| 52-Week Change | -29.01 |
| 52-Week High | 7.75 |
| 52-Week Low | 3.71 |
| Moving Average 50 Days | 4.87 |
| Moving Average 200 Days | 4.92 |
| Average Volume | 193,854 |
| Shares Outstanding | 23.46M |
| % Held by Institutions | 48.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |